Your 25-second video preview has ended.
to continue watching, please Log In or Register:
Treatment and Management Options for RVO
Jordi Monés, MD, PhD, of the Institut de la Macula I de la Retina in Barcelona, Spain, shares highlights from the symposium addressing RVO disease. Dr. Monés discusses management strategies and addresses their efficacy and safety. He also explains why he chooses Lucentis for treating patients with BRVO and CRVO.
Novartis Pharma AG
CH-4002 Basel, Switzerland ©2015 Novartis Pharma AG January 2015 GLRET/LUC/0292d